No Data
Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?
Institutional Shareholders May Be Less Affected by Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Pullback Last Week After a Year of 0.5% Returns
Express News | Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Press Release: Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025
Stock_Drift : Mmmmm, nice.
DCCTrader : Bidders overtaking askers need to break 6.00$ otherwise very very long hold ..anyway buy signal in quarterly may can break over within next 3-6 months